Watchlist Manager

Watchlist

Price: 26.11 CNY -0.76%

Market Cap: ¥13.7B

Z	Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SZSE:300357	CN

Income Statement

Currency: CNY

	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	1	1	1	1	1	1	1	1	0	0
Revenue	194 N/A	202 +5%	211 +4%	228 +8%	240 +5%	247 +3%	252 +2%	261 +3%	267 +2%	277 +4%	283 +2%	303 +7%	312 +3%	324 +4%	344 +6%	367 +7%	386 +5%	411 +7%	439 +7%	478 +9%	501 +5%	532 +6%	557 +5%	615 +11%	639 +4%	612 -4%	625 +2%	631 +1%	636 +1%	691 +9%	724 +5%	765 +6%	808 +6%	841 +4%	849 +1%	888 +5%	896 +1%	882 -2%	893 +1%	870 -3%	848 -2%	881 +4%	891 +1%	905 +2%	925 +2%	938 +1%	980 +5%	1 049 +7%
Gross Profit
Cost of Revenue	(7)	(9)	(11)	(11)	(10)	(12)	(13)	(13)	(13)	(15)	(14)	(14)	(12)	(12)	(12)	(13)	(14)	(22)	(25)	(32)	(29)	(29)	(27)	(26)	(23)	(26)	(31)	(31)	(29)	(34)	(33)	(35)	(34)	(40)	(40)	(44)	(41)	(47)	(49)	(46)	(40)	(47)	(49)	(51)	(45)	(56)	(57)	(60)
Gross Profit	186 N/A	194 +4%	201 +4%	217 +8%	230 +6%	235 +2%	239 +2%	247 +3%	254 +3%	263 +3%	269 +2%	290 +8%	301 +4%	312 +4%	331 +6%	355 +7%	372 +5%	390 +5%	414 +6%	446 +8%	472 +6%	503 +6%	529 +5%	589 +11%	617 +5%	586 -5%	594 +1%	600 +1%	608 +1%	657 +8%	691 +5%	730 +6%	773 +6%	801 +4%	809 +1%	844 +4%	855 +1%	834 -2%	844 +1%	823 -2%	808 -2%	834 +3%	842 +1%	854 +1%	881 +3%	882 +0%	924 +5%	989 +7%
Operating Income
Operating Expenses	(105)	(117)	(116)	(121)	(123)	(116)	(118)	(121)	(127)	(131)	(136)	(141)	(152)	(153)	(156)	(161)	(167)	(170)	(182)	(198)	(220)	(237)	(254)	(281)	(300)	(299)	(304)	(312)	(314)	(328)	(353)	(372)	(409)	(413)	(406)	(423)	(485)	(495)	(522)	(529)	(494)	(506)	(515)	(530)	(544)	(554)	(563)	(570)
Selling, General & Administrative	(95)	(115)	(114)	(120)	(112)	(115)	(117)	(120)	(116)	(129)	(135)	(140)	(142)	(151)	(155)	(158)	(159)	(168)	(178)	(193)	(204)	(223)	(232)	(253)	(257)	(253)	(253)	(253)	(260)	(279)	(299)	(317)	(330)	(341)	(341)	(357)	(355)	(365)	(379)	(380)	(373)	(401)	(410)	(427)	(423)	(446)	(454)	(463)
Research & Development	(10)	0	0	0	(11)	0	0	0	(10)	0	0	0	(9)	0	0	(2)	(8)	0	0	(3)	(11)	(14)	(22)	(31)	(35)	(46)	(52)	(60)	(56)	(74)	(79)	(81)	(75)	(95)	(98)	(103)	(92)	(104)	(107)	(108)	(96)	(118)	(122)	(122)	(99)	(119)	(119)	(118)
Depreciation & Amortization	(0)	0	0	0	(0)	0	0	0	(1)	0	0	0	(1)	0	0	0	(1)	0	0	0	(4)	0	0	0	(7)	0	0	0	(12)	0	0	0	(22)	0	0	0	(24)	0	0	0	(33)	0	0	0	(44)	0	0	0
Other Operating Expenses	(0)	(2)	(2)	(1)	(0)	(1)	(1)	(1)	(0)	(2)	(1)	(1)	(0)	(2)	(1)	(1)	1	(0)	(2)	(2)	(0)	(0)	0	3	0	0	0	0	15	25	26	26	18	22	33	37	(14)	(27)	(37)	(41)	8	14	17	18	21	11	11	12
Operating Income	81 N/A	77 -5%	85 +10%	97 +14%	107 +10%	119 +12%	121 +2%	126 +4%	127 +1%	132 +4%	133 +1%	148 +12%	148 0%	160 +8%	176 +10%	194 +10%	205 +6%	220 +7%	232 +6%	248 +7%	252 +2%	266 +5%	275 +3%	308 +12%	317 +3%	287 -9%	289 +1%	288 -1%	294 +2%	328 +12%	339 +3%	357 +6%	364 +2%	388 +6%	403 +4%	421 +5%	369 -12%	339 -8%	322 -5%	294 -9%	314 +7%	328 +4%	327 0%	323 -1%	337 +4%	328 -3%	361 +10%	419 +16%
Pre-Tax Income
Interest Income Expense	1	1	2	3	6	7	8	8	7	7	7	7	8	8	9	10	12	13	15	17	19	22	24	26	27	26	26	28	27	28	29	27	29	30	30	30	27	27	27	26	31	30	31	37	32	37	36	31
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	(5)	(5)	(5)	(5)	(0)	(0)	(0)	(0)	(0)	0	0	0	0	0	0	0	0	0	0	0	(0)	(0)	(0)	(0)	(0)	0	0	0	(0)	0	0	1	(1)	1	1	1
Gain/Loss on Disposition of Assets	0	0	0	0	0	0	0	0	0	0	0	(4)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Total Other Income	2	2	5	5	7	6	5	5	5	5	2	2	0	1	1	5	3	2	1	2	2	1	3	4	2	4	3	9	1	(0)	1	(7)	0	1	(0)	0	3	2	2	1	1	1	(2)	(3)	(3)	(5)	(4)	(5)
Pre-Tax Income	83 N/A	80 -4%	92 +15%	105 +13%	119 +14%	132 +11%	134 +2%	139 +4%	139 0%	143 +3%	142 -1%	154 +8%	152 -1%	164 +8%	181 +11%	205 +13%	219 +7%	235 +7%	248 +6%	266 +7%	273 +3%	289 +6%	302 +5%	337 +12%	346 +2%	317 -8%	318 +0%	325 +2%	323 -1%	356 +10%	368 +4%	378 +2%	393 +4%	418 +6%	432 +3%	451 +4%	399 -11%	367 -8%	351 -5%	322 -8%	346 +8%	359 +4%	356 -1%	358 +1%	365 +2%	361 -1%	394 +9%	446 +13%
Net Income
Tax Provision	(13)	(12)	(14)	(15)	(19)	(22)	(23)	(23)	(21)	(21)	(21)	(25)	(23)	(25)	(27)	(29)	(33)	(35)	(37)	(40)	(41)	(44)	(46)	(52)	(53)	(49)	(50)	(52)	(53)	(58)	(61)	(65)	(67)	(71)	(72)	(72)	(63)	(54)	(49)	(45)	(50)	(57)	(59)	(60)	(61)	(59)	(62)	(69)
Income from Continuing Operations	71	68	78	90	100	110	112	116	118	122	121	129	129	139	154	175	186	200	211	227	232	245	257	286	293	267	268	273	270	297	308	313	326	348	360	379	336	314	301	277	296	302	296	298	304	302	332	377
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	1	2	3	5	6	6	7	8	9	10	11	11	12	12	11	12	13	14	15	15	15	14	14	14	13	13	13	13
Net Income (Common)	71 N/A	68 -4%	78 +16%	90 +14%	100 +11%	111 +11%	112 +1%	116 +4%	118 +2%	122 +4%	121 -1%	129 +7%	129 N/A	139 +8%	154 +11%	175 +14%	186 +6%	200 +7%	211 +6%	227 +7%	233 +3%	247 +6%	259 +5%	290 +12%	298 +3%	274 -8%	275 +1%	281 +2%	278 -1%	308 +10%	319 +4%	324 +2%	338 +4%	359 +6%	372 +3%	391 +5%	349 -11%	328 -6%	316 -3%	292 -8%	310 +6%	317 +2%	311 -2%	312 +0%	318 +2%	315 -1%	346 +10%	390 +13%
EPS (Diluted)	0.15 N/A	0.14 -7%	0.2 +43%	0.17 -15%	0.19 +12%	0.21 +11%	0.22 +5%	0.23 +5%	0.23 N/A	0.23 N/A	0.23 N/A	0.24 +4%	0.25 +4%	0.26 +4%	0.29 +12%	0.33 +14%	0.36 +9%	0.38 +6%	0.4 +5%	0.43 +7%	0.44 +2%	0.47 +7%	0.49 +4%	0.55 +12%	0.57 +4%	0.52 -9%	0.53 +2%	0.54 +2%	0.53 -2%	0.58 +9%	0.6 +3%	0.61 +2%	0.65 +7%	0.69 +6%	0.71 +3%	0.75 +6%	0.67 -11%	0.63 -6%	0.6 -5%	0.56 -7%	0.59 +5%	0.61 +3%	0.59 -3%	0.6 +2%	0.61 +2%	0.6 -2%	0.66 +10%	0.75 +14%

Income Statement Balance Sheet Cash Flow Statement

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Income Statement

Earnings Waterfall
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Income Statement
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd SZSE:300357

Income Statement

Earnings Waterfall Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Income Statement Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

See Also

Company

Help

Tools

Stocks

Zhejiang Wolwo Bio-Pharmaceutical Co Ltd
SZSE:300357

Earnings Waterfall
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd

Income Statement
Zhejiang Wolwo Bio-Pharmaceutical Co Ltd